目的探讨MAGE-1基因编码的肿瘤相关抗原作为肝细胞性肝癌（HCC）主动免疫治疗攻击靶点的可能性。
Objective To explore the possibility of tumor associated antigen encoded by MAGE-1gene used as a tarest for immunotherapy in HCC patients.
原发性肝细胞癌、转移性肝癌、局灶性结节增生、炎性假瘤在MRSP各期中表现不同。
Primary hepatic carcinoma, hepatic metastases, focal nodular hyperplasia, and inflammatory pseudotumor were presented as different MR features on each phase of MRSP.
目的：探讨肝细胞肝癌超声造影峰值强度与血管生成的相关性，以期为临床提供无创性血管生成的评估指标。
Purpose: in order to assess the angiogenesis of hepatocellular carcinoma, the peak intensity in contrast ultrasonography of the lesions was compared with the findings of immunohistochemistry.
其中肝细胞性肝癌77例(84.6%)，胆管癌9例(9.9%)，混合细胞性肝癌2例(2.2%)和肝母细胞瘤3例(3.3%)。
Among all the cases studies, 77 (84.6%) were of hepatocellular carcinoma, 9 (9.9%) of cholangiocarcinoma, 2 (2.2%) of mixed cell carcinoma, and 3 (3.3%;) of hepatoblastoma.
其中肝细胞性肝癌77例(84.6%)，胆管癌9例(9.9%)，混合细胞性肝癌2例(2.2%)和肝母细胞瘤3例(3.3%)。
Among all the cases studies, 77 (84.6%) were of hepatocellular carcinoma, 9 (9.9%) of cholangiocarcinoma, 2 (2.2%) of mixed cell carcinoma, and 3 (3.3%;) of hepatoblastoma.
应用推荐